First Trust Large Cap Core AlphaDEX FundFEX

The First Trust Large Cap Core AlphaDEX Fund (FEX) is a large-cap US equity ETF that uses NASDAQ’s proprietary AlphaDEX methodology to screen and rank stocks by value, momentum, and quality factors before assembling them into a portfolio. The fund’s mandate is to track the NASDAQ US 500 Large Cap Core Index, which is itself a rules-based selection of 500 large-cap US stocks. The AlphaDEX twist is that it ranks these stocks using a multi-factor model, then weights them in a way that tilts the portfolio toward the highest-ranked stocks. The fund’s expense ratio is 0.61%, which is higher than a pure passive index fund but within the typical range for an actively tilted ETF. The fund trades on NASDAQ under the ticker FEX, and its liquidity is tracked by NASDAQ’s market data feed.

What FEX actually does is offer a mechanically tilted version of the S&P 500, with the tilt engineered by NASDAQ’s factor model. The fund’s top holdings are dominated by the usual suspects-Apple, Microsoft, Nvidia, Amazon, Alphabet-because large-cap US equities are, by definition, concentrated in the biggest names. The AlphaDEX methodology doesn’t promise to relative strength; it promises to apply a screen that may or may not work in practice. The fund’s prospectus, filed with the SEC via EDGAR, is a document that reads like a legal crossword puzzle designed to confuse rather than clarify, with disclaimers about how the methodology’s effectiveness depends on market conditions and factor performance. The fund’s liquidity is monitored by NASDAQ, and its daily volume is visible in real time, but the fund’s actual performance versus its benchmark is the real test of whether the tilt adds value or just adds noise.

The SEC’s EDGAR filing for FEX confirms the fund’s structure as a series of First Trust Exchange-Traded Fund III, a legal wrapper that is as opaque as it is necessary. The filing includes the fund’s prospectus, which outlines the AlphaDEX methodology, the rebalancing schedule, and the fee structure. The prospectus also notes that the fund may lag its benchmark before fees, which is a polite way of saying the fund’s edge is not guaranteed. The filing does not provide performance history, revenue, profit, or any other financial metrics beyond the fund’s expense ratio and the methodology description. The fund’s liquidity and AUM are tracked by NASDAQ and FINRA, but these figures are snapshots that do not reflect the fund’s long-term trajectory.

FEX’s chart is available on NASDAQ’s market data page, where the fund’s price and volume are displayed alongside its benchmark index. The chart shows the fund’s daily price movements, but it does not reveal whether the AlphaDEX tilt is working or whether the fund’s performance is driven by the underlying index rather than the methodology. The fund’s liquidity is decent, but liquidity in ETFs is a function of trading volume and market conditions, not the fund’s methodology. The fund’s expense ratio is fixed at 0.61%, which is a known drag on performance that the source requires readers to accept if they want the tilt.

What changed this week: nothing material. The fund’s holdings, expense ratio, and methodology remain unchanged, and there are no new filings or earnings reports to parse. The fund’s liquidity and volume are tracked by NASDAQ and FINRA, but these figures do not reveal whether the AlphaDEX screen is adding value or just adding cost. The fund’s performance relative to its benchmark is the only real test of the methodology, and the evidence does not yet establish whether the tilt works in practice.

What remains unproven: whether the AlphaDEX methodology consistently adds value after fees. The fund’s prospectus and SEC filing outline the methodology, but they do not provide backtested performance data or forward-looking guarantees. The fund’s liquidity and volume are tracked by NASDAQ and FINRA, but these figures do not reveal whether the tilt is effective. The fund’s expense ratio is known and fixed, but the value of the tilt is not. The evidence needed to deepen the file would be a third-party backtest of the AlphaDEX methodology versus the fund’s benchmark, or a multi-year performance track record that demonstrates consistent relative strength after fees. Until then, FEX is a rules-based tilt wrapped in a fee, and the only certainty is the expense ratio.